DNA vaccines: A key for inducing long-term cellular immunity

Current Opinion in Immunology

Volumn 12, Issue 4, 2000, Pages 442-447

  Gurunathan, Sanjay ^a   Wu, Chang Yu ^a   Freidag, Brenda L ^a   Seder, Robert A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; PLASMID DNA;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; GENETIC TRANSFECTION; HUMORAL IMMUNITY; LEISHMANIA MAJOR; MALARIA; MYCOBACTERIUM TUBERCULOSIS; REVIEW; SOMATIC CELL; TH1 CELL;

ANIMALS; ANTIGEN PRESENTATION; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALARIA; PLASMIDS; TH1 CELLS; TIME FACTORS; TUBERCULOSIS; VACCINES, DNA;

EID: 0034086797     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00118-7     Document Type: Review

References (54)

1. Robinson H.L. DNA vaccines: basic mechanism and immune responses. Int J Mol Med. 4:1999;549-555.
2. Gurunathan S., Klinman D., Seder R.A. DNA vaccines: immunology, application and optimisation. Annu Rev Immunol. 18:2000;927-974.
3. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
4. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
5. Cardon L.R., Burge C., Clayton D.A., Karlin S. Pervasive CpG suppression in animal mitochondrial genomes. Proc Natl Acad Sci USA. 91:1994;3799-3803.
6. Razin A., Friedman J. DNA methylation and its possible biological roles. Prog Nucl Acid Res Mol Biol. 25:1981;33-52.
7. Halpern M.D., Kurlander R.J., Pisetsky D.S. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α Cell Immunol. 167:1996;72-78.
8. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ Proc Natl Acad Sci USA. 93:1996;2879-2883.
9. Cowdery J.S., Chace J.H., Yi A.K., Krieg A.M. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol. 156:1996;4570-4575.
10. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol. 158:1997;3635-3639.
11. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxy-nucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol. 161:1998;3042-3049.
12. Brazolot Millan C.L., Weeratna R., Krieg A.M., Siegrist C.A., Davis H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci USA. 95:1998;15553-15558.
13. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 160:1998;870-876.
14. Klinman D.M. Therapeutic applications of CpG-containing oligodeoxynucleotides. Antisense Nucl Acid Drug Dev. 8:1998;181-184.
15. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., Yi A.K., Short D., Davis H.L. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA. 95:1998;12631-12636.
16. Hacker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., Heeg K., Lipford G.B., Wagner H. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:1998;6230-6240.
17. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest. 98:1996;1119-1129.
18. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
19. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., De Witt C.M., Friedman A.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
20. Ulmer J.B., Deck R.R., Dewitt C.M., Donnhly J.I., Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology. 89:1996;59-67.
21. Agadjanyan M.G., Kim J.J., Trivedi N., Wilson D.M., Monzavi-Karbassi B., Morrison L.D., Nottingham L.K., Dentchev T., Tsai A., Dang K.et al. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J Immunol. 162:1999;3417-3427.
22. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol. 158:1997;4591-4601.
23. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol. 158:1997;4529-4532.
24. Yang N.S., Burkholder J., Roberts B., Martinell B., McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA. 87:1990;9568-9572.
25. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A.et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA. 91:1994;9519-9523.
26. Klinman D.M., Sechler J.M., Conover J., Gu M., Rosenberg A.S. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J Immunol. 160:1998;2388-2392.
27. Corr M., von Damm A., Lee D.J., Tighe H. In vivo priming by DNA injection occurs predominantly by antigen transfer. J Immunol. 163:1999;4721-4727.
28. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med. 189:1999;169-178. Elegant paper showing that dendritic cells are transfected in vivo. Also provides information about how long-term responses are generated.
29. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med. 184:1996;1555-1560.
30. Iwasaki A., Torres C.A., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol. 159:1997;11-14.
31. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA. 93:1996;8578-8583.
32. Casares S., Inaba K., Brumeanu T.D., Steinman R.M., Bona C.A. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med. 186:1997;1481-1486.
33. + T cells after gene gun immunization. J Exp Med. 188:1998;1075-1082.
34. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med. 2:1996;1122-1128.
35. Vremec D., Shortman K. Dendritic cell subtypes in mouse lymphoid organs. Cross-correlation of surface markers, changes with incubation and differences among thymus, spleen and lymph nodes. J Immunol. 159:1997;565-573.
36. Pulendran B., Lingappa J., Kennedy M.K., Smith J., Teepe M., Rudensky A., Maliszewski C.R., Maraskovsky E. Developmental pathways of dendritic cells in vivo. J Immunol. 159:1997;2222-2231.
37. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med. 189:1999;587-592.
38. Staerz U.D., Karasuyama H., Garner A.M. Cytotoxic T lymphocytes against a soluble protein. Nature. 329:1987;449-451.
39. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol. 153:1994;4925-4933.
40. Falo L.D. Jr., Kovacsovics-Bankowski M., Thompson K., Rock K.L. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med. 1:1995;649-653.
41. Udono H., Srivastava P.K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 178:1993;1391-1396.
42. Fu T.M., Ulmer J.B., Caulfield N.J., Deck R.R., Friedman A., Wang S., Liu X., Donnelly J.J., Liu M.A. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med. 3:1997;362-371.
43. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89.
44. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via αVβ5 and CD36, and cross-present antigens to cytotoxic lymphocytes. J Exp Med. 188:1998;1359-1368.
45. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 191:2000;423-433. Recent paper defining the role of apoptosis and necrosis in the cross-priming and maturation, respectively, of dendritic cells.
46. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med. 177:1993;1505-1509.
47. Zimmermann S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol. 160:1998;3627-3630.
48. Gurunathan S., Prussin C., Sacks D.L., Seder R.A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat Med. 4:1998;1409-1415.
49. Wang R.B., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y.P., Jones T.R., Hobart P., Margalit M., Ng J.et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.
50. van Rie A., Warren R., Richardson M., Victor T.C., Gie R.P., Enarson D.A., Beyers N., van Helden P.D. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 341:1999;1174-1179.
51. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., DeWitt C.M., Orme I.M., Baldwin S., D'Souza C.et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med. 2:1996;893-898.
52. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory E., Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nat Med. 2:1996;888-892.
53. Freidag B.L., Melton G.B., Collins F., Klinman D., Cheever A., Stobie L., Suen W., Seder R.A. CpG oligodeoxynucleotides and IL-12 improve the efficacy of BCG vaccination in mice challenged with Mycobacterium tuberculosis. Infect Immun. 68:2000;2948-2953.
54. Lowie D.B., Tascon R.E., Bonato V.L.D., Lima V.M.F., Faccioli L.H., Stavropoulos E., Colston M.J., Hewinson R.G., Moelling K., Silva C.L. Therapy of tuberculosis in mice by DNA vaccination. Nature. 400:1999;269-271. Recent paper suggesting that DNA vaccination may be effective as a therapeutic vaccine for systemic tuberculosis infection.